Iradimed (IRMD) Short Interest Ratio & Short Volume $52.96 +0.10 (+0.19%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Iradimed Short Interest DataIradimed (IRMD) has a short interest of 201,000 shares, representing 2.51% of the float (the number of shares available for trading by the public). This marks a 16.45% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 43,386 shares to cover all short positions.Current Short Interest201,000 sharesPrevious Short Interest172,600 sharesChange Vs. Previous Month+16.45%Dollar Volume Sold Short$10.84 millionShort Interest Ratio4.7 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares12,715,000 sharesFloat Size8,020,000 sharesShort Percent of Float2.51%Today's Trading Volume27,431 sharesAverage Trading Volume43,386 sharesToday's Volume Vs. Average63% Short Selling Iradimed? Sign up to receive the latest short interest report for Iradimed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIRMD Short Interest Over TimeIRMD Days to Cover Over TimeIRMD Percentage of Float Shorted Over Time Remove Ads Iradimed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2025201,000 shares $10.84 million +16.5%2.5%4.7 $53.91 2/15/2025172,600 shares $9.53 million +12.8%2.2%4.1 $55.23 1/31/2025153,000 shares $9.06 million +2.9%1.9%3.7 $59.21 1/15/2025148,700 shares $8.74 million +19.8%1.9%3.7 $58.78 12/31/2024124,100 shares $6.83 million +18.2%1.6%3.1 $55.00 12/15/2024105,000 shares $5.53 million +22.0%1.3%2.7 $52.63 11/30/202486,100 shares $4.64 million +0.2%1.1%2.2 $53.93 11/15/202485,900 shares $4.47 million +6.3%1.1%2 $51.99 10/31/202480,800 shares $3.98 million +4.0%1.0%1.9 $49.27 10/15/202477,700 shares $3.91 million +4.4%1.0%1.6 $50.35 Get the Latest News and Ratings for IRMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iradimed and its competitors with MarketBeat's FREE daily newsletter. 9/30/202474,400 shares $3.74 million +8.9%0.9%1.5 $50.29 9/15/202468,300 shares $3.31 million -11.5%0.9%1.3 $48.47 8/31/202477,200 shares $3.63 million -25.8%1.0%1.5 $46.96 8/15/2024104,000 shares $4.69 million -27.2%1.3%2.1 $45.13 7/31/2024142,800 shares $6.67 million -2.7%1.8%2.8 $46.71 7/15/2024146,700 shares $6.74 million +2.4%1.8%3 $45.96 6/30/2024143,200 shares $6.29 million +6.9%1.8%3 $43.94 6/15/2024134,000 shares $5.80 million +40.0%1.7%3 $43.25 5/31/202495,700 shares $4.06 million -2.0%1.2%2 $42.47 5/15/202497,600 shares $4.11 million -6.2%1.2%2 $42.15 4/30/2024104,000 shares $4.22 million -0.9%1.3%2 $40.61 4/15/2024104,900 shares $4.29 million -3.2%1.3%1.9 $40.88 3/31/2024108,400 shares $4.77 million -4.0%1.4%2 $43.99 3/15/2024112,900 shares $5.00 million +11.0%1.4%2.1 $44.27 2/29/2024101,700 shares $4.27 million +5.7%1.3%1.9 $41.97 2/15/202496,200 shares $4.50 million +24.1%1.2%2 $46.76 1/31/202477,500 shares $3.21 million +3.5%1.0%1.8 $41.41 1/15/202474,900 shares $3.39 million -3.2%1.0%2.2 $45.30 12/31/202377,400 shares $3.67 million -43.9%1.0%2.2 $47.47 12/15/2023137,900 shares $6.30 million +81.2%1.7%4.2 $45.68 11/30/202376,100 shares $3.34 million -4.9%1.0%2.5 $43.94 11/15/202380,000 shares $3.42 million -19.8%1.1%2.4 $42.74 10/31/202399,700 shares $4.06 million +16.6%1.3%3 $40.74 10/15/202385,500 shares $3.26 million -12.8%1.1%2.6 $38.17 9/30/202398,000 shares $4.35 million +7.0%1.3%2.8 $44.37 9/15/202391,600 shares $4.28 million +20.5%1.2%2.6 $46.71 8/31/202376,000 shares $3.51 million -7.2%1.0%2.1 $46.23 8/15/202381,900 shares $4.08 million -16.9%1.1%2.5 $49.76 7/31/202398,500 shares $4.33 million +13.7%1.3%2.9 $43.93 7/15/202386,600 shares $4.04 million -3.7%1.2%2.5 $46.60Musk’s real agenda in D.C. (Ad)In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…Here’s the full story. 6/30/202389,900 shares $4.29 million -11.1%1.2%2.8 $47.74 6/15/2023101,100 shares $5.06 million +1.1%1.5%3 $50.09 5/31/2023100,000 shares $4.70 million +14.2%1.4%3 $47.03 5/15/202387,600 shares $4.01 million No Change1.2%2.4 $45.83 10/31/2022157,900 shares $4.59 million -11.5%2.2%5.8 $29.05 10/15/2022178,500 shares $5.05 million +2.7%2.5%6.8 $28.30 9/30/2022173,800 shares $5.22 million +2.6%2.4%6.8 $30.06 9/15/2022169,400 shares $5.40 million -6.3%2.4%5.9 $31.88 8/31/2022180,800 shares $6.07 million -6.2%2.5%6.1 $33.55 8/15/2022192,700 shares $7.56 million -1.1%2.7%6.3 $39.22 7/31/2022194,900 shares $8.23 million -6.6%2.7%5.2 $42.25 7/15/2022208,700 shares $7.68 million -1.0%2.9%4.2 $36.80 6/30/2022210,900 shares $7.16 million +11.2%3.0%3.9 $33.94 6/15/2022189,700 shares $6.14 million +4.6%2.7%2.8 $32.39 5/31/2022181,400 shares $5.93 million +0.8%2.5%2.4 $32.69 5/15/2022180,000 shares $5.90 million +9.3%2.5%2.1 $32.78 4/30/2022164,700 shares $5.42 million +0.3%2.3%1.8 $32.91 4/15/2022164,200 shares $7.26 million +10.9%2.3%1.8 $44.23 3/31/2022148,100 shares $6.64 million +17.0%N/A0 $44.84 3/15/2022126,600 shares $5.91 million -5.3%1.8%1.5 $46.66 2/28/2022133,700 shares $6.64 million -4.0%2.0%1.7 $49.70 2/15/2022139,300 shares $6.96 million -11.9%2.1%1.5 $49.99 1/31/2022158,100 shares $6.30 million +27.2%2.4%1.9 $39.82 1/15/2022124,300 shares $5.47 million +32.2%N/A1.7 $44.04 12/31/202194,000 shares $4.34 million -6.0%1.4%1.5 $46.21 12/15/2021100,000 shares $4.51 million +25.8%1.5%1.9 $45.12 11/30/202179,500 shares $3.58 million +20.5%1.2%1.6 $45.00 11/15/202166,000 shares $2.62 million -33.7%1.0%1.9 $39.72 10/29/202199,500 shares $3.71 million -4.5%1.5%4.1 $37.32 10/15/2021104,200 shares $3.82 million -2.3%1.6%4.7 $36.67 9/30/2021106,700 shares $3.58 million -11.7%1.7%2.6 $33.59 9/15/2021120,800 shares $4.29 million +6.2%1.9%2.9 $35.54 8/31/2021113,700 shares $3.84 million +3.0%1.8%2.8 $33.76 8/13/2021110,400 shares $3.75 million -11.6%1.7%2.9 $33.93 7/30/2021124,900 shares $4.20 million +17.2%2.0%3.3 $33.66 7/15/2021106,600 shares $3.59 million +15.4%1.7%3 $33.66 6/30/202192,400 shares $2.72 million -8.6%1.5%3.5 $29.41 6/15/2021101,100 shares $3.01 million -0.8%1.6%6.7 $29.79 5/28/2021101,900 shares $2.83 million +1.1%1.6%5.3 $27.81 5/14/2021100,800 shares $2.85 million -4.9%1.6%4.8 $28.26 4/30/2021106,000 shares $2.84 million -1.1%1.7%4.9 $26.76 4/15/2021107,200 shares $2.70 million -12.1%1.7%4.1 $25.18 3/31/2021121,900 shares $2.89 million -0.2%2.0%4.6 $23.74 3/15/2021122,100 shares $2.81 million -0.6%2.0%4.3 $22.98 2/26/2021122,800 shares $2.79 million +3.4%2.0%5 $22.70 2/12/2021118,800 shares $2.96 million -35.7%1.9%4.8 $24.88 1/29/2021184,700 shares $4.60 million +36.0%3.0%7.1 $24.89 1/15/2021135,800 shares $3.31 million +0.1%2.2%5.7 $24.37 12/31/2020135,700 shares $3.19 million -11.3%2.2%5.4 $23.50 12/15/2020153,000 shares $3.76 million -5.7%2.5%5.4 $24.59Musk’s real agenda in D.C. (Ad)In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…Here’s the full story. 11/30/2020162,200 shares $3.88 million -1.3%2.6%5 $23.92 11/15/2020164,300 shares $3.75 million -10.2%2.7%4.6 $22.80 10/30/2020183,000 shares $4.02 million +10.4%3.0%5.1 $21.95 10/15/2020165,700 shares $3.63 million -32.9%2.7%4.1 $21.92 9/30/2020247,100 shares $5.28 million -13.2%4.0%6 $21.38 9/15/2020284,800 shares $6.19 million -14.7%4.6%5.7 $21.72 8/31/2020334,000 shares $7.08 million -6.0%5.4%6.8 $21.20 8/14/2020355,200 shares $7.82 million -8.8%5.8%6.9 $22.01 7/31/2020389,300 shares $8.67 million -5.0%6.5%7.5 $22.28 7/15/2020409,800 shares $9.69 million -5.8%6.9%8 $23.64 6/30/2020435,100 shares $10.00 million +12.7%7.3%8.5 $22.98 6/15/2020386,000 shares $8.99 million -1.0%6.5%8 $23.28 5/29/2020389,900 shares $8.70 million -0.6%6.6%8.3 $22.31 5/15/2020392,400 shares $8.00 million -12.0%6.5%8.5 $20.39 4/30/2020446,100 shares $9.71 million -4.7%7.4%9.1 $21.76 4/15/2020468,000 shares $9.12 million +7.6%7.9%9.7 $19.48 3/31/2020434,900 shares $8.84 million -0.2%7.3%8.5 $20.32 IRMD Short Interest - Frequently Asked Questions What is Iradimed's current short interest? Short interest is the volume of Iradimed shares that have been sold short but have not yet been covered or closed out. As of February 28th, traders have sold 201,000 shares of IRMD short. 2.51% of Iradimed's shares are currently sold short. Learn More on Iradimed's current short interest. What is a good short interest ratio for Iradimed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IRMD shares currently have a short interest ratio of 5.0. Learn More on Iradimed's short interest ratio. Which institutional investors are shorting Iradimed? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Iradimed: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Iradimed? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.51% of Iradimed's floating shares are currently sold short. Is Iradimed's short interest increasing or decreasing? Iradimed saw a increase in short interest in February. As of February 28th, there was short interest totaling 201,000 shares, an increase of 16.5% from the previous total of 172,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Iradimed's float size? Iradimed currently has issued a total of 12,715,000 shares. Some of Iradimed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Iradimed currently has a public float of 8,020,000 shares. How does Iradimed's short interest compare to its competitors? 2.51% of Iradimed's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Iradimed: TransMedics Group, Inc. (29.89%), Soleno Therapeutics, Inc. (14.37%), LivaNova PLC (2.92%), Enovis Co. (9.88%), NovoCure Limited (5.31%), Warby Parker Inc. (10.50%), LeMaitre Vascular, Inc. (5.59%), CONMED Co. (7.98%), Cadre Holdings, Inc. (7.40%), Tandem Diabetes Care, Inc. (11.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Iradimed stock? Short selling IRMD is an investing strategy that aims to generate trading profit from Iradimed as its price is falling. IRMD shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Iradimed? A short squeeze for Iradimed occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IRMD, which in turn drives the price of the stock up even further. How often is Iradimed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IRMD, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies TransMedics Group Short Interest Data Soleno Therapeutics Short Interest Data LivaNova Short Interest Data Enovis Short Interest Data NovoCure Short Interest Data Warby Parker Short Interest Data LeMaitre Vascular Short Interest Data CONMED Short Interest Data Cadre Short Interest Data Tandem Diabetes Care Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IRMD) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iradimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Iradimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IRMD Stock Free IRMD Stock Alerts